ArticleJournal of breast cancer2020

Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer.

Min Chong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.